RenJi Hospital
757
158
173
138
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.8%
6 terminated/withdrawn out of 757 trials
95.8%
+9.3% vs industry average
12%
88 trials in Phase 3/4
4%
5 of 138 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (757)
Laparoscopic Staging for Stage III Gastric Cancer
Role: collaborator
A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.
Role: collaborator
A Study of BEN301 Injection in theTreatment of Autoimmune Diseases
Role: lead
A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
Role: collaborator
Acute Myocardial Infarction Clinical Cohort
Role: collaborator
Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding
Role: collaborator
Modified Tumor-free Techniques Operation to Cervical Cancer
Role: collaborator
Durg Coated Balloon Angioplasty in Infrapopliteal Lesions
Role: collaborator
A Real-world Study to Evaluate the Primary Patency and Freedom From TLR of Endovascular Treatment in TOSAKA III In-stent Restenosis of Lower Extremity Femoropopliteal Artery.
Role: collaborator
China Cognition and Aging Study
Role: collaborator
The Chinese Familial Alzheimer's Network
Role: collaborator
A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)
Role: collaborator
Total-body 13N-NH3 PET/CT to Study the Blood Perfusion in Severe AS Patients Pre- and Post-TAVR in Whole Body
Role: lead
INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)
Role: collaborator
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
Role: collaborator
Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders
Role: lead
Biochemical Response and Clinical Outcomes in Patients With PBC
Role: lead
Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
Role: collaborator
Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia
Role: lead
The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions
Role: lead